Sociedade Brasileira de Hematologia e Hemoterapia
Sociedade Brasileira de Hematologia e Hemoterapia
 

  NOVOS SÓCIOS

Seja sócio da SBHH!
Faça o cadastro!
Faça seu cadastro!

  NAVEGADOR SBHH

Busca de Artigos Científicos
Controle de Qualidade Externo em Imuno-hematologia
Controle de Qualidade em Hemoterapia
HEMO 2007
Datas Comemorativas da Área da Saúde
Ética Médica
Legislação
Links
Publicações
Quem é Quem nos Hemocentros
Sala de Imprensa

SBHH Responde

Doação de Sangue
Onde, como e quem pode?

EUROPEAN JOURNAL OF HAEMATOLOGY 78 (6) - Junho 2007

Original Articles

Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML

Angèle Herry, Nathalie Douet-Guilbert, Frédéric Morel, Marie-Josée Le Bris, Marc De Braekeleer

p.457–467

The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG)

David R. Betts, Roland A. Ammann, Andreas Hirt, Heinz Hengartner, Maja Beck-Popovic, Thomas Kuhne, Luisa Nobile, Ueli Caflisch, Pierre Wacker, Felix K. Niggli

p.468–476

Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group

Pirjo Koistinen, Riikka Räty, Maija Itälä, Esa Jantunen, Elli Koivunen, Tapio Nousiainen, Tarja-Terttu Pelliniemi, Kari Remes, Tapani Ruutu, Eeva-Riitta Savolainen, Timo Siitonen, Raija Silvennoinen, Liisa Volin, Erkki Elonen for the Finnish Leukaemia Group

p.477–486

Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality

Masaaki Takatoku, Takashi Uchiyama, Shinichiro Okamoto, Yuzuru Kanakura, Kenichi Sawada, Masao Tomonaga, Shinji Nakao, Tatsutoshi Nakahata, Mine Harada, Takashi Murate, Keiya Ozawa on behalf of the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes

p.487–494

Oral health risks associated with HLA-types of patients undergoing hematopoietic stem cell transplantation

Tereza Dobr, Jakob Passweg, Catherine Weber, André Tichelli, Dominik Heim, Jürg Meyer, Alois Gratwohl, Tuomas Waltimo

p.495–499

Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study

Aline Schmidt, Odile Blanchet, Mamoun Dib, Michel F. Baslé, Norbert Ifrah, Daniel Chappard

p.500–509

Lysophosphatidic acid protection against apoptosis in the human pre-B-cell line Nalm-6

Yumiko Satoh, Ryunosuke Ohkawa, Kazuhiro Nakamura, Katsumi Higashi, Makoto Kaneko, Hiromitsu Yokota, Junken Aoki, Hiroyuki Arai, Yasuhito Yuasa, Yutaka Yatomi

p.510–517

Health-related quality of life measured by the Short Form 36 in immune thrombocytopenic purpura: a cross-sectional survey in China

Zeping Zhou, Li Yang, Zhenping Chen, Xiaoli Chen, Ye Guo, Xiaoyan Wang, Xunwei Dong, Tingting Wang, Lei Zhang, Zhiyong Qiu, Renchi Yang

p.518–523

Predictive value of discrimination indices in differential diagnosis of iron deficiency anemia and beta-thalassemia trait

Cengiz Beyan, Kürsat Kaptan, Ahmet Ifran

p.524–526

Neurotoxicity upon infusion of dimethylsulfoxide-cryopreserved peripheral blood stem cells in patients with and without pre-existing cerebral disease

Lutz P. Mueller, Sebastian Theurich, Maximilian Christopeit, Wilfried Grothe, Anke Muetherig, Thomas Weber, Susanne Guenther, Gerhard Behre

p.527–531

A cost-effectiveness analysis of caspofungin vs. liposomal amphotericin B for treatment of suspected fungal infections in the UK

Karin Bruynesteyn, Vanya Gant, Catherine McKenzie, Tony Pagliuca, Chris Poynton, Ritesh N. Kumar, Jeroen P. Jansen

p.532–539

Case Reports

Correction of anemia in a transfusion-dependent patient with primary myelofibrosis receiving iron chelation therapy with deferasirox (Exjade®, ICL670)

Anna Angela Di Tucci, Roberta Murru, Daniele Alberti, Bertrand Rabault, Simona Deplano, Emanuele Angelucci

p.540–542

 

 

Acute myeloid leukaemia secondary to treatment with capecitabine for metastatic colorectal cancer

Susan Shapiro, George Hughes, Magda Jabbar Al-Obaidi, Eamon O’Reilly, Subramanian Ramesh, Jason Smith, Riz Ahmad, Charlotte Dawson, Pippa Riddle, Mallika Sekhar

p.543–544

Letters to the Editor

Rapid elimination of circulating leukemia cells with a small dose of alemtuzumab in refractory aggressive NK-cell leukemia

Makoto Sasaki, Koichi Sugimoto, Shimpei Kawahara, Hajime Yasuda, Hiroko Suto, and Kazuo Oshimi

p.545–545

Reply to Sue Richards’ Letter to the Editor: ‘Omission of evidence from review on prophylaxis of fungal infections’

Johan Maertens

p.546–546

Omission of evidence from review on prophylaxis of fungal infections

Sue Richards

p.546–546

Clinical Pictures

Acute myeloblastic leukaemia (AML-M1) presenting with prominent gingival hypertrophy

Atilla Ozkan, Ridvan Ali, Fahir Ozkalemkas, Tulay Ozcelik, Vildan Ozkocaman

p.547–547

Isolated granulocytic sarcoma involving the mediastinum and bilateral cervical lymph nodes

Vassilios Vassiliou, Christos Christopoulos, Dimitrios Kardamakis, Maria Tinniakou, Maria Puglisi, Dimitrios Vomvas, Panagiota Matsouka

p.548–548


  Sociedade Brasileira de Hematologia e Hemoterapia
  Rua da Assembléia, nº 10 Grupo 1704 - Centro - Rio de Janeiro - RJ - Brasil - CEP 20011-901
  Tel/Fax: +55 (21) 3511-1101